Clinical Trials Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial 05 Mar 2021
ADC Therapeutics doses first patient in Phase II trial of ADCT-402 ADC Therapeutics has dosed the first patient in a Phase II clinical trial to examine... 8th August 2018
Clinical Trials Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial 05 Mar 2021
Clinical Trials Dicerna and Roche start Phase II trial of GalXC RNAi candidate in hepatitis B 05 Mar 2021
Clinical Trials Marker Therapeutics treats first subject in acute myeloid leukaemia trial 04 Mar 2021